Menu
Live News EQUITY L impact

EIKN Joins Russell 3000

Eikon Therapeutics to join the Russell 3000 Index, reflecting progress as a publicly traded company

EIKN

EIKN - Eikon Therapeutics to Join the Russell 3000® IndexAddition reflects Eikon's progress as a publicly traded company and increasing visibility within the investment community